Mustang Bio effects 1-for-50 reverse stock split to regain Nasdaq compliance

MUSTANG BIO, INC.

Outstanding shares reduced from ~64.8M to ~1.3M; split effective Jan 15, 2025.
Trading on split-adjusted basis under symbol MBIO begins Jan 16, 2025.
Reverse split intended to meet Nasdaq's $1.00 minimum bid price requirement.
No fractional shares issued; cash payment in lieu for fractional entitlements.
New CUSIP 62818Q302; board set final ratio on Jan 6, 2025 per prior stockholder approval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.